• 11/27/2024

Requiem for an Alzheimer’s Drug

Wall Street Journal

Biogen’s research developing Aduhelm paved the way for other anti-amyloid treatments.

https://www.wsj.com/articles/aduhelm-biogen-alzheimers-treatment-drug-development-pharma-fda-1d866bd7